Moreover, the combination of creatine supplementation with PD-1/PD-L1 blockade therapy provides a continuous supply of energy to T cells, effectively preventing tumor progression for a long time and significantly improving T cell-based cancer immunotherapies. The gene discussed is PDCD1; the disease is neoplasm.